COMPANY
Stem Pharm
Funding and NIH signals
- NIH award NIH awarded $971K (SBIR Phase II 2R44AG082625-02, competing renewal, notice Sep 17, 2026). NIH RePORTER 2R44AG082625-02 (Sep 17, 2026)
Evidence (1 event)
- Sep 17, 2026 · NIH RePORTER 2R44AG082625-02
Organization: STEM PHARM, INC.; City/State: MADISON, WI; Project number: 2R44AG082625-02; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-09-17; FY total cost (award amount): 971368; Administering IC: National Institute on Aging; Project title: Alzheimer's Disease Drug Discovery Using a Human Organoid Model of Neuroinflammation; Organization type: Domestic For-Profits
- Sep 17, 2026 · NIH RePORTER 2R44AG082625-02
Timeline
- Grant Government grant — SBIR: $971,368 (annual award, as published), announced Sep 17, 2026. Agency: NIH/NIA. Source: government award database. source ↗
Funding
- Government grant — SBIR: $971,368 (annual award, as published), announced Sep 17, 2026. Agency: NIH/NIA. Source: government award database. source ↗
NIH awards 13
- NIH award 1R43NS139845-01 FY2024: $499,953 awarded for that fiscal year; activity R43 (SBIR); PI LEBAKKEN, CONNIE S; recipient as written: STEM PHARM, INC., MADISON, WI. Development and Validation of a CNS Organoid M source ↗
- NIH award 3R43AG082625-01A1S1 FY2024: $55,000 awarded for that fiscal year; activity R43 (SBIR); PI LEBAKKEN, CONNIE S; recipient as written: STEM PHARM, INC., MADISON, WI. Human Neural Organoid Modeling of Alzheimer source ↗
- NIH award 1R43AG082625-01A1 FY2023: $499,903 awarded for that fiscal year; activity R43 (SBIR); PI LEBAKKEN, CONNIE S; recipient as written: STEM PHARM, INC., MADISON, WI. Human Neural Organoid Modeling of Alzheimer' source ↗
- NIH award 1R41CA281533-01A1 FY2023: $406,500 awarded for that fiscal year; activity R41 (STTR); PI LEBAKKEN, CONNIE S; recipient as written: STEM PHARM, INC., MADISON, WI. Neural organoid models of the immunological source ↗
- NIH award 5R44ES029898-03 FY2022: $783,533 awarded for that fiscal year; activity R44 (SBIR); PI LEBAKKEN, CONNIE S; recipient as written: STEM PHARM, INC., MADISON, WI. Hydrogel-enabled self-assembled human brain or source ↗
- NIH award 5R44NS102088-03 FY2021: $678,585 awarded for that fiscal year; activity R44 (SBIR); PI LEBAKKEN, CONNIE S; recipient as written: STEM PHARM, INC., MADISON, WI. Synthetic hydrogels for biomanufacturing of iP source ↗
- NIH award 2R44ES029898-02A1 FY2021: $930,433 awarded for that fiscal year; activity R44 (SBIR); PI LEBAKKEN, CONNIE S; recipient as written: STEM PHARM, INC., MADISON, WI. Hydrogel-enabled self-assembled human brain source ↗
- NIH award 2R44NS102088-02A1 FY2020: $868,100 awarded for that fiscal year; activity R44 (SBIR); PI LEBAKKEN, CONNIE S; recipient as written: STEM PHARM, INC., MADISON, WI. Synthetic hydrogels for biomanufacturing of source ↗
- NIH award 1R43ES029898-01A1 FY2019: $225,000 awarded for that fiscal year; activity R43 (SBIR); PI LEBAKKEN, CONNIE S; recipient as written: STEM PHARM, INC., MADISON, WI. Hydrogel-enabled self-assembled human brain source ↗
- NIH award 3R43ES029897-01S1 FY2019: $55,000 awarded for that fiscal year; activity R43 (SBIR); PI LEBAKKEN, CONNIE S; recipient as written: STEM PHARM, INC., MADISON, WI. Synthetic biomaterials designed for the gener source ↗
- NIH award 1R43NS102088-01A1 FY2018: $224,976 awarded for that fiscal year; activity R43 (SBIR); PI LEBAKKEN, CONNIE S; recipient as written: STEM PHARM, INC., MADISON, WI. Synthetic hydrogels for biomanufacturing of source ↗
- NIH award 1R43ES029897-01 FY2018: $225,000 awarded for that fiscal year; activity R43 (SBIR); PI LEBAKKEN, CONNIE S; recipient as written: STEM PHARM, INC., MADISON, WI. Synthetic biomaterials designed for the genera source ↗
- NIH award 1R43TR001904-01 FY2017: $290,999 awarded for that fiscal year; activity R43 (SBIR); PI LEBAKKEN, CONNIE S; recipient as written: STEM PHARM, INC., MADISON, WI. Biomaterials for mRNA-based cellular reprogram source ↗